ODTX

Odyssey Therapeutics, Inc.Closed

17.24−1.02 −5.59%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 17.24 0.00%

Open

18.15

Prev close

18.26

Day range

17.1818.40

52-week range

15.1029.05

Volume

258.82K0.98×

Mkt cap

828.53M

P/E ttm

—

Fwd P/E

-4.15

EPS ttm

-7.55

Div yield

0.00%

Earnings

Aug 4, 2026

From 52w high

−40.65%

Price Chart

Yahoo Finance · delayed

ODTXOct 13, 2026O 18.15H 18.40L 17.18C 17.24−1.02 (−5.59%)Vol 258.80K

SMA 5022.53
SMA 200—

1Y change +4.99% since May 8, 2026 close109 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

Date	Insider	Transaction	Shares	Value
May 10, 2026	Leiden Jeffrey MDirector	—	31.7K	—
May 10, 2026	Sr One Capital Management, LlcBeneficial Owner of more than 10% of a Class of Security	Purchase at price 18.00 per share.	555.6K	$10.00M
May 10, 2026	Sr One Capital Management, LlcBeneficial Owner of more than 10% of a Class of Security	Sale at price 18.00 per share.	1.8K	$32.04K
May 10, 2026	Sr One Capital Management, LlcBeneficial Owner of more than 10% of a Class of Security	—	3.24M	—
May 10, 2026	Tpg Gp A, L.L.C.Beneficial Owner of more than 10% of a Class of Security	Purchase at price 18.00 per share.	1.39M	$25.00M
May 10, 2026	Tpg Gp A, L.L.C.Beneficial Owner of more than 10% of a Class of Security	—	1.88M	—
May 10, 2026	Chu ShelleyDirector	Purchase at price 18.00 per share.	11.1K	$200.00K
May 10, 2026	Li Nan LnDirector	Purchase at price 18.00 per share.	1.11M	$20.00M
May 10, 2026	Li Nan LnDirector	—	1.71M	—
May 10, 2026	Opipari Anthony W M.D., Ph.D.Officer	—	7.5K	—
May 10, 2026	Glick Gary D. Ph.D.Chief Executive Officer	—	27.4K	—
May 7, 2026	Leiden Jeffrey MDirector	Purchase at price 16.42 per share.	5K	$82.10K
May 7, 2026	Haas JasonChief Financial Officer	Purchase at price 16.42 per share.	1K	$16.42K
May 7, 2026	Dimension Capital Ii, L.P.Beneficial Owner of more than 10% of a Class of Security	Purchase at price 18.00 per share.	1.11M	$20.00M
May 7, 2026	Dimension Capital Ii, L.P.Beneficial Owner of more than 10% of a Class of Security	—	1.71M	—

Date	Insider	Transaction	Shares	Value
May 10, 2026	Leiden Jeffrey MDirector	—	31.7K	—
May 10, 2026	Sr One Capital Management, LlcBeneficial Owner of more than 10% of a Class of Security	Purchase at price 18.00 per share.	555.6K	$10.00M
May 10, 2026	Sr One Capital Management, LlcBeneficial Owner of more than 10% of a Class of Security	Sale at price 18.00 per share.	1.8K	$32.04K
May 10, 2026	Sr One Capital Management, LlcBeneficial Owner of more than 10% of a Class of Security	—	3.24M	—
May 10, 2026	Tpg Gp A, L.L.C.Beneficial Owner of more than 10% of a Class of Security	Purchase at price 18.00 per share.	1.39M	$25.00M
May 10, 2026	Tpg Gp A, L.L.C.Beneficial Owner of more than 10% of a Class of Security	—	1.88M	—
May 10, 2026	Chu ShelleyDirector	Purchase at price 18.00 per share.	11.1K	$200.00K
May 10, 2026	Li Nan LnDirector	Purchase at price 18.00 per share.	1.11M	$20.00M
May 10, 2026	Li Nan LnDirector	—	1.71M	—
May 10, 2026	Opipari Anthony W M.D., Ph.D.Officer	—	7.5K	—
May 10, 2026	Glick Gary D. Ph.D.Chief Executive Officer	—	27.4K	—
May 7, 2026	Leiden Jeffrey MDirector	Purchase at price 16.42 per share.	5K	$82.10K
May 7, 2026	Haas JasonChief Financial Officer	Purchase at price 16.42 per share.	1K	$16.42K
May 7, 2026	Dimension Capital Ii, L.P.Beneficial Owner of more than 10% of a Class of Security	Purchase at price 18.00 per share.	1.11M	$20.00M
May 7, 2026	Dimension Capital Ii, L.P.Beneficial Owner of more than 10% of a Class of Security	—	1.71M	—

ODTX

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

ODTX

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Odyssey Therapeutics, Inc.

Insider Activity · ODTX

Congress Trades · ODTX

Investors Holding ODTX

Investors Holding ODTX

Congress Trades · ODTX

Insider Activity · ODTX

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Odyssey Therapeutics, Inc.

Financial Snapshot

Earnings & Dividends

News